focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Group Regulatory News (SAG)

Share Price Information for Science Group (SAG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 452.00
Bid: 444.00
Ask: 460.00
Change: -14.00 (-3.00%)
Spread: 16.00 (3.604%)
Open: 466.00
High: 466.00
Low: 445.00
Prev. Close: 466.00
SAG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

12 Oct 2020 07:00

RNS Number : 7080B
Science Group PLC
12 October 2020
 

 

 

 

 

12 October 2020

 

 

 

 

Science Group plc

(the "Group" or "Science Group")

 

 

Trading Update

 

Science Group announces that, following its trading update on 10 September 2020, revenue across the Group has continued to be at the higher end of the Board's expectations. In particular, the performance of Frontier is noteworthy in terms of both revenue and, due to an enhanced product mix, an improved operating margin. While the Board is using the opportunity to increase investments in the operating businesses, it is now apparent that the Group's adjusted operating profit for the year ended 31 December 2020 will exceed the Group's expectations as set out at the start of the year.

 

Frontier Smart Technologies

 

The acquisition of Frontier was completed one year ago this week. The restructuring and integration programme was executed rapidly and, in hindsight, would have been very challenging if it had not been completed before the outbreak of the pandemic. While the business was disrupted by Covid-19 in the first half of the year, demand for Frontier products has continued the recovery seen in the early summer, with shipments in 2020 now constrained by materials supply and orders booked for shipments in early 2021 now approaching 50% of the first quarter forecast.

 

The benefit of this uptick in demand is enhanced by an increasing proportion of SmartRadio modules (combined DAB, Internet Radio and music/podcast streaming services) in the product mix which have a higher average selling price than DAB-only modules. It is unclear whether this is a longer term trend at this stage, although Smart Radio sell through can be validated by tracking the quantity of first-time connections to the Nuvola IoT infrastructure and the data obtained supports the view of market growth in this sub-sector since mid-April.

 

As a result, after many years of losses, for the year to 31 December 2020 it is now anticipated that Frontier will slightly exceed the revenue plan set out at the start of the year and operating margins for the year are now anticipated to be broadly in line with the rest of the Group. In summary, Frontier has exceeded the Board's expectations in its first year post-acquisition.

 

Employee Appreciation and Charitable Donations

 

In achieving such a strong performance in this challenging year, the employees of Science Group have demonstrated their resilience, commitment and determination. The Board expresses its gratitude for this dedication and has awarded a one-off bonus of £500 to all eligible, permanent employees (pro-rated for part-time staff and localised for employees outside the UK).

 

In addition, early in the pandemic, the Board recognised the potential impact on some sectors of society and provided support to local food banks. Unfortunately, as we enter winter, Covid-19 remains firmly established and charitable sector fund raising continues to be very severely constrained. In light of the Group's successful financial performance, the Board has decided to increase the Group's charitable donations in 2020 to further support local communities in these difficult times.

 

2021 Outlook

 

The global economic environment remains unpredictable and the future will be subject to the effects of Covid-19, Brexit and the US Presidential election. Realistically it is impossible to incorporate such a combination of factors into a business plan. The Board will therefore continue its prudent operating model, making investments when financial results permit, and maintaining its primary focus on cash flow. This model, which is consistently implemented in every acquisition, has delivered resilient performance over the past decade, even during the pandemic .

 

Science Group also benefits from its strong balance sheet including gross cash (excluding client held funds) at 30 September 2020 of £25.0 million and net funds of £8.2 million, with the debt secured on the Group's substantial freehold property (office and laboratory) assets. This capital base enables the Board to continue to explore acquisition opportunities although, as always, there can be no certainty that any acquisitions will be completed.

 

 

 

 

End

 

Science Group plc

 

Martyn Ratcliffe, Chairman

Tel: +44 (0) 1223 875 200

Rebecca Archer, Finance Director

www.sciencegroup.com

 

 

Stifel Nicolaus Europe Limited (Nominated Adviser and Joint Broker)

 

Nick Adams, Alex Price

Tel: +44 (0) 20 7710 7600

 

 

Liberum Capital Limited (Joint Broker)

 

Neil Patel, Cameron Duncan

Tel: +44 (0) 20 3100 2000

 

 

 

 

 

 

 

 

 

Note: This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation (No 596/2014). The person responsible for this announcement is Rebecca Archer, Finance Director.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUAUBRRRURAAA
Date   Source Headline
2nd Oct 20237:00 amRNSTransaction in Own Shares
27th Sep 20237:00 amRNSTransaction in Own Shares
26th Sep 20237:00 amRNSTransaction in Own Shares
18th Sep 20237:00 amRNSTransaction in Own Shares
13th Sep 20237:00 amRNSTransaction in Own Shares
12th Sep 20237:00 amRNSTransaction in Own Shares
5th Sep 20237:00 amRNSHolding(s) in Company
2nd Aug 202312:34 pmRNSHolding(s) in Company
1st Aug 20237:00 amRNSTotal Voting Rights
28th Jul 20237:00 amRNSTreasury shares issued & PDMR dealing
27th Jul 20237:00 amRNSTreasury shares issued
24th Jul 20237:00 amRNSInterim results for 6 months ended 30 June 2023
18th Jul 20231:35 pmRNSNotice of Interim Results
13th Jul 20237:00 amRNSHolding(s) in Company
12th Jun 20234:33 pmRNSHolding(s) in Company
12th Jun 20237:00 amRNSTransaction in Own Shares
18th May 202311:50 amRNSResult of AGM
18th May 20237:00 amRNSAGM Trading and Board Update
15th May 20237:00 amRNSIssue of share options & PDMR dealing
12th May 20232:05 pmRNSHolding(s) in Company
9th May 20237:00 amRNSTransaction in Own Shares
3rd May 20237:00 amRNSTransaction in Own Shares
2nd May 20237:00 amRNSTransaction in Own Share & Total Voting Rights
27th Apr 20237:00 amRNSTransaction in Own Shares
26th Apr 20237:00 amRNSTransaction in Own Shares
25th Apr 20237:00 amRNSTransaction in Own Shares
24th Apr 20237:00 amRNSTransaction in Own Shares
21st Apr 20237:00 amRNSTransaction in Own Shares
19th Apr 20237:00 amRNSTransaction in Own Shares
18th Apr 20237:00 amRNSPosting of documents and Notice of AGM
12th Apr 20237:00 amRNSTransaction in Own Shares
6th Apr 20237:00 amRNSTransaction in Own Shares
5th Apr 20237:00 amRNSTransaction in Own Shares
4th Apr 20237:00 amRNSTransaction in Own Shares
3rd Apr 20237:00 amRNSTransaction in Own Shares
31st Mar 20237:00 amRNSTransaction in Own Shares
30th Mar 20237:00 amRNSTransaction in Own Shares
29th Mar 20237:00 amRNSTransaction in Own Shares
21st Mar 20237:00 amRNSAudited Results for Year Ended 31 December 2022
16th Mar 20231:00 pmRNSNotice of Preliminary Results
14th Mar 20234:45 pmRNSHolding(s) in Company
14th Mar 20233:00 pmRNSHolding(s) in Company
13th Mar 20237:00 amRNSStatement re banking arrangements
13th Mar 20237:00 amRNSBanking Arrangements
2nd Mar 20233:06 pmRNSHolding(s) in Company
10th Feb 20231:20 pmRNSHolding(s) in Company
9th Feb 20232:45 pmRNSHolding(s) in Company
3rd Feb 20237:00 amRNSCompletion of Sale of Westek Technology Ltd
31st Jan 202312:25 pmRNSHolding(s) in Company
31st Jan 202311:35 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.